Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells
Dwight H. Owen, Brooke Benner, Carly Pilcher, Logan Good, Himanshu Savardekar, Ruthann Norman, Christian Ghattas, Manisha H. Shah, Bhavana Konda, Claire F. Verschraegen, Robert Wesolowski, Gregory K. Behbehani, William E. Carson, Gregory A. Otterson
Topics & Concepts
NivolumabMedicineTemozolomideLung cancerOncologyBiomarkerMyeloidClinical trialCancer researchInternal medicineCancerImmunotherapyChemotherapyBiologyBiochemistryLung Cancer Research StudiesCancer therapeutics and mechanismsPeptidase Inhibition and Analysis